alphaherpesvirus
compris
close
relat
virus
man
anim
includ
herp
simplex
viru
varicellazost
viru
pseudorabi
viru
prv
use
methylbetacyclodextrin
fluoresc
tag
prv
directli
show
deplet
cholesterol
plasma
membran
host
cell
significantli
reduc
prv
entri
cholesterol
deplet
reduc
prv
attach
stall
viru
particl
plasma
membran
penetr
cell
cholesterol
deplet
result
destabil
lipid
raft
microdomain
plasma
membran
shown
involv
effici
entri
differ
virus
signific
fraction
prv
virion
appear
local
juxtapos
lipid
raft
marker
entri
togeth
data
indic
cholesterol
possibl
cholesterolrich
lipid
raft
may
import
prv
entri
alphaherpesviru
subfamili
herpesvirus
consist
close
relat
member
includ
herp
simplex
viru
hsv
porcin
pseudorabi
viru
prv
varicellazost
viru
vzv
bovin
herpesviru
type
equin
herpesviru
type
prv
often
use
model
subfamili
studi
gener
aspect
alphaherpesviru
replic
spread
pomeranz
et
al
prv
virion
consist
core
linear
doubl
strand
dna
genom
icosahedr
capsid
larg
amorph
protein
mass
call
tegument
envelop
embed
often
glycosyl
envelop
protein
alphaherpesvirus
larg
virus
complex
virion
structur
use
cellular
machineri
differ
aspect
replic
cycl
cholesterol
repres
one
key
constitu
small
dynam
steroland
sphingolipidenrich
domain
plasma
membran
call
lipid
raft
compartment
cellular
process
pike
remov
cholesterol
plasma
membran
lead
loss
lipid
raft
function
approach
wide
use
determin
possibl
role
lipid
raft
differ
process
mani
virus
human
immunodefici
viru
hiv
viard
et
al
sever
acut
respiratori
syndromecoronaviru
sar
li
et
al
murin
coronaviru
choi
et
al
polioviru
danthi
chow
human
herpesviru
huang
et
al
vaccinia
viru
chung
et
al
footandmouth
diseas
viru
martinaceb
et
al
report
depend
plasma
membran
cholesterol
specif
lipid
raft
effici
entri
howev
indic
literatur
possibl
role
cholesterol
andor
lipid
raft
alphaherpesviru
entri
role
lipid
raft
alphaherpesviru
infect
suggest
base
associ
herp
simplex
viru
envelop
protein
gb
envelop
glycoprotein
gd
gc
gh
lipid
raft
entri
bender
et
al
also
report
hsv
entri
suppress
cholesterol
deplet
chelat
bender
et
al
infect
vzv
sensit
treatment
hambleton
et
al
indic
role
cholesterol
earli
stage
alphaherpesviru
infect
mani
studi
report
determin
effect
cholesterol
deplet
viru
entri
assess
immediateearli
gene
express
hsv
infecti
foci
format
vzv
therefor
complet
discrimin
effect
cholesterol
deplet
differ
postattach
stage
entri
penetr
capsid
transport
nucleu
genom
deposit
nucleu
onset
viral
gene
express
aim
current
studi
assess
directli
role
plasma
membran
cholesterol
alphaherpesviru
entri
use
porcin
alphaherpesviru
pseudorabi
viru
prv
determin
role
cholesterol
andor
lipid
raft
differ
step
alphaherpesviru
entri
attach
penetr
transport
nucleu
directli
assess
effect
deplet
cholesterol
host
cell
plasma
membran
prv
entri
assess
whether
prv
virion
coloc
lipid
raft
marker
upon
attach
host
cell
entri
prv
host
cell
assess
h
pi
fluoresc
tag
prv
capsid
protein
fuse
gfp
calcul
number
perinuclear
virion
ie
virion
enter
cell
assess
import
cholesterol
prv
entri
plasma
membran
cholesterol
remov
cell
adhes
mm
methylbetacyclodextrin
mbcd
treatment
either
replenish
addit
cholesterol
cholesterol
measur
amplex
red
cholesterol
assay
kit
reveal
mbcd
treatment
remov
cholesterol
effici
cholesterol
content
restor
addit
cholesterol
fig
entri
analyz
quantit
entri
prv
reduc
significantli
mbcd
treatment
reduct
number
perinuclear
virion
rel
control
cell
fig
c
replet
cellular
cholesterol
mbcd
treatment
addit
cholesterol
restor
reduct
reduct
rel
control
cell
addit
cholesterol
reduct
rel
control
cell
addit
cholesterol
fig
c
indic
plasma
membran
cholesterol
play
import
role
entri
prv
particl
host
cell
confirm
green
puncta
observ
repres
viru
particl
composit
viral
inoculum
analyz
immunofluoresc
fig
observ
gfp
puncta
inoculum
found
colabel
gb
therefor
repres
envelop
viru
particl
henc
gfp
detect
current
assay
repres
viru
particl
puncta
singl
posit
gb
similar
size
viru
particl
also
frequent
observ
puncta
may
perhap
repres
capsidless
lparticl
describ
sever
alphaherpesvirus
aleman
et
al
subaksharp
dargan
cholesterol
deplet
reduc
attach
prv
stall
viru
particl
plasma
membran
entri
alphaherpesvirus
host
cell
subdivid
three
step
attach
host
cell
penetr
transport
capsid
nucleu
along
microtubul
determin
step
entri
cholesteroldepend
total
number
virion
percentag
plasma
membraneassoci
perinuclear
virion
determin
mbcdtreat
cell
untreat
control
cell
suspens
fig
suspens
assay
facilit
analysi
allow
flow
cytometr
measur
mbcd
treatment
caus
similar
reduct
entri
cell
suspens
observ
cell
adhes
perinuclear
virion
control
cell
versu
mbcdtreat
cell
mbcd
treatment
affect
total
number
virion
associ
host
cell
versu
control
cell
indic
cholesterol
deplet
affect
virion
attach
flow
cytometr
assay
perform
confirm
viru
attach
host
cell
affect
mbcd
treatment
flow
cytometr
assay
perform
temperatur
viru
attach
host
cell
penetr
cell
mbcd
treatment
reduc
attach
prv
host
cell
fig
extra
control
pretreat
cell
heparin
found
reduc
fluoresc
signal
level
mock
signal
indic
attach
specif
entri
assay
suspens
also
reveal
much
higher
percentag
virion
plasma
membraneassoci
mbcdtreat
cell
compar
control
cell
fig
togeth
data
indic
cholesterol
deplet
reduc
attach
prv
host
cell
stall
viru
particl
immedi
underneath
plasma
membran
indic
cholesterol
deplet
suppress
viral
entri
level
penetr
level
initi
transport
capsid
nucleu
confoc
flow
cytometr
assay
describ
fulli
discrimin
whether
mbcd
treatment
stall
viru
particl
attach
penetr
attach
penetr
engag
microtubulemedi
transport
nucleu
determin
whether
virion
stall
plasma
membran
mbcd
treatment
pass
membran
use
trypsinbas
assay
trypsinbas
assay
use
remov
nonintern
particl
plasma
membran
nishi
saigo
contrast
virion
pass
plasma
membran
virion
bound
plasma
membran
pass
remov
trypsin
treatment
cell
trypsin
treatment
effici
remov
particl
plasma
membran
control
experi
cell
inocul
fig
b
lower
panel
trypsin
treatment
also
remov
almost
plasma
membraneassoci
virion
mbcdtreat
cell
fig
b
middl
panel
c
expect
number
perinuclear
virion
mbcdtreat
cell
affect
trypsin
treatment
fig
indic
mbcd
treatment
suppress
penetr
prv
host
cell
signific
fraction
prv
appear
local
juxtapos
lipid
raft
marker
entri
cholesterol
major
constitu
lipid
raft
depend
cholesterol
effici
entri
differ
virus
suggest
use
lipid
raft
entri
platform
nayak
hui
ono
freed
rawat
et
al
howev
virus
hiv
vaccinia
viru
direct
role
lipid
raft
viral
entri
shown
coloc
viral
protein
viru
receptor
raft
marker
entri
chung
et
al
popik
alc
popik
et
al
assess
whether
direct
indic
role
lipid
raft
microdomain
entri
prv
analyz
whether
virion
coloc
lipid
raft
marker
harder
et
al
entri
juxtapos
associ
patch
real
imag
cfr
b
upper
panel
control
imag
cfr
b
lower
panel
indic
differ
real
imag
control
imag
posit
rel
signific
level
prv
particl
obvious
coloc
show
random
distribut
either
signific
fraction
viru
particl
appear
local
juxtapos
small
overlap
fluoresc
signal
viru
particl
signal
fig
minor
particl
found
fulli
coloc
spot
stain
minor
particl
found
associ
spot
stain
similar
juxtapos
local
prv
observ
live
cell
fix
data
shown
howev
cover
larg
fraction
cell
surfac
agreement
find
kenworthi
et
al
sinc
total
lipid
raft
area
constitut
larg
fraction
cell
surfac
addit
experi
set
exclud
possibl
frequent
observ
juxtapos
local
prv
lipid
raft
chanc
effect
end
lipid
raft
aggreg
larger
cluster
patch
describ
harder
et
al
addit
viru
signific
fraction
prv
virion
appear
local
juxtapos
cluster
fig
upper
panel
c
patch
process
affect
entri
effici
viru
data
shown
extra
blind
control
unrel
imag
prv
virion
patch
merg
virion
local
score
result
significantli
less
juxtapos
local
virion
versu
real
imag
p
valu
significantli
virion
associ
versu
real
imag
p
valu
fig
lower
panel
c
conclus
signific
fraction
prv
appear
local
juxtapos
lipid
raft
marker
entri
remov
plasma
membran
cholesterol
cyclodextrin
mbcd
found
significantli
reduc
prv
entri
cholesterol
deplet
reduc
attach
stall
viru
particl
plasma
membran
penetr
cell
indic
plasma
membran
cholesterol
import
prv
cross
plasma
membran
effici
moreov
signific
fraction
prv
appear
local
juxtapos
lipid
raft
marker
entri
indic
lipid
raft
involv
prv
entri
cholesterol
deplet
cyclodextrin
treatment
use
evalu
import
plasma
membran
cholesterol
lipid
raft
entri
virus
howev
effect
treatment
entri
often
evalu
directli
assess
express
report
gene
sever
hour
postinocul
bender
et
al
chung
et
al
assess
viru
product
amount
viral
dnarna
cell
choi
et
al
danthi
chow
li
et
al
assess
infecti
foci
format
hambleton
et
al
observ
effect
cyclodextrin
often
attribut
effect
entri
compar
effect
cell
pretreat
cell
treat
postentri
stage
choi
et
al
chung
et
al
danthi
chow
hambleton
et
al
li
et
al
current
studi
evalu
role
cholesterol
entri
alphaherpesviru
prv
direct
manner
fluoresc
tag
viru
particl
enter
cell
h
pi
quantifi
allow
us
conclud
great
certainti
observ
effect
cholesterol
deplet
due
hamper
viral
entri
step
viral
infect
use
techniqu
also
allow
us
distinguish
differ
stage
entri
attach
penetr
capsid
transport
nucleu
flow
cytometr
analysi
determin
virion
local
viru
sensit
trypsin
treatment
reveal
stage
entri
affect
mbcd
attach
host
cell
penetr
plasma
membran
import
cholesterol
andor
lipid
raft
viral
entri
relat
differ
aspect
viral
entri
process
lipid
raft
could
creat
favour
environ
around
target
membran
receptor
facilit
oligomer
co
receptor
recognit
co
receptor
viru
burger
et
al
viard
et
al
anoth
explan
may
signal
transduct
molecul
particularli
concentr
lipid
raft
brown
brown
london
dykstra
et
al
helm
zurzolo
simon
toomr
facilit
specif
step
viral
entri
penetr
transport
capsid
nucleu
eg
human
herpesviru
lipid
raft
suggest
import
modif
signal
molecul
microtubul
dynam
nuclear
deliveri
dispens
bind
penetr
raghu
et
al
import
lipid
raft
also
due
requir
specif
class
lipid
associ
lipid
raft
cholesterol
also
sphingolipid
concept
lipid
recognit
certain
protein
might
import
factor
viral
entri
teissier
pecheur
retrovir
entri
specif
lipid
appar
role
conform
chang
lead
proper
exposur
fusion
peptid
toward
target
membran
alfsen
bomsel
chazal
gerlier
membran
curvatur
mainli
depend
molecular
shape
lipid
lipid
also
play
key
role
membran
deform
requir
penetr
plasma
membran
teissier
pecheur
observ
signific
fraction
prv
appear
local
juxtapos
lipid
raft
marker
entri
may
suggest
weak
partial
raft
associ
facilit
penetr
weak
partial
interact
raft
agreement
find
bender
et
al
hsv
bender
et
al
use
flotat
assay
author
found
viral
glycoprotein
gb
gd
gc
gh
hsv
receptor
hvem
nectin
associ
lipid
raft
entri
interact
mediat
ectodomain
gb
bender
et
al
author
hypothes
cellular
gb
receptor
enrich
raft
size
alphaherpesviru
envelop
would
allow
virion
interact
simultan
raft
nonraft
domain
attach
observ
signific
fraction
prv
appear
local
juxtapos
lipid
raft
marker
entri
line
partial
peripher
lipid
raft
associ
alphaherpesvirus
entri
perhap
peripheri
lipid
raft
form
boundari
cholesterolrich
rigid
raft
membran
fluid
phospholipidrich
plasma
membran
el
kirat
morandat
may
provid
benefici
environ
penetr
host
cell
also
possibl
weak
partial
associ
alphaherpesvirus
raft
entri
affect
raftassoci
signal
cascad
may
involv
subsequ
penetr
although
current
studi
point
import
role
cholesterol
prv
penetr
indic
partial
associ
prv
lipid
raft
entri
research
need
fulli
clarifi
exact
physic
role
lipid
raft
cholesterol
alphaherpesviru
entri
conclus
found
effici
penetr
host
cell
prv
requir
plasma
membran
cholesterol
signific
fraction
prv
particl
appear
local
juxtapos
lipid
raft
marker
entri
may
open
new
insight
mechan
alphaherpesviru
entri
may
also
lead
novel
antivir
strategi
porcin
biotinyl
polyclon
antiprv
antibodi
prepar
antiprv
hyperimmun
serum
nauwynck
pensaert
accord
manufactur
instruct
amersham
intern
mic
buckinghamshir
uk
dilut
mous
monoclon
antibodi
gb
describ
earlier
use
dilut
nauwynck
pensaert
amplex
red
cholesterol
assay
kit
streptavidintexa
red
use
goatantimous
texa
red
use
texa
redx
phalloidin
use
purchas
invitrogen
molecular
probe
eugen
mbcd
watersolubl
cholesterol
triton
heparin
sodium
salt
porcin
intestin
mucosa
trypsin
porcin
pancrea
stock
solut
pb
biotinyl
cholera
toxin
b
subunit
stock
solut
mgml
ultra
pure
water
use
purchas
sigma
sigma
chemic
co
st
loui
mo
ethylenediaminetetraacetet
acid
disodiumsalt
edta
stock
solut
wv
pb
purchas
normapur
fontenay
sou
boi
franc
fluoresc
variant
prv
creat
fuse
gene
encod
capsid
protein
gene
encod
gfp
smith
et
al
kindli
provid
g
smith
l
enquist
h
postseed
coverslip
well
plate
swine
kidney
sk
cell
wash
rpmi
medium
inocul
variant
prv
multipl
infect
moi
rpmi
medium
cell
incub
h
allow
viral
entri
wash
twice
pb
thereaft
fixat
perform
paraformaldehyd
pfa
pb
permeabil
step
perform
viru
outer
side
cell
stain
biotinyl
antiprv
antibodi
follow
streptavidintexa
red
mount
glycerinpb
solut
vol
vol
diazabicyclo
octan
janssen
chimica
beers
belgium
glycerindabco
cell
analyz
use
tc
laser
scan
spectrum
confoc
system
leica
microsystem
gmbh
heidelberg
germani
seri
confoc
section
taken
area
within
cell
sequenti
gfp
argon
nm
laserlin
texa
red
grene
nm
laserlin
spectrum
merg
imag
number
perinuclear
virion
virion
carri
gfp
label
area
cell
count
cell
count
per
experi
independ
repeat
experi
perform
statist
analysi
data
perform
spss
softwar
spss
inc
geometr
mean
number
perinuclear
virion
count
per
cell
differ
treatment
transform
compar
anova
tamhan
test
geometr
mean
confid
interv
present
analyz
composit
inoculum
inoculum
dri
apesco
microscop
slide
fix
methanol
stain
gb
viral
envelop
protein
mous
antigb
monoclon
antibodi
follow
goatantimous
texa
red
h
seed
coverslip
well
plate
sk
cell
wash
rpmi
medium
treat
mm
mbcd
rpmi
h
wash
twice
pb
cholesterol
either
replenish
incub
cell
cholesterol
rpmi
medium
h
wash
pb
quantit
entri
assay
perform
describ
effici
cholesterol
remov
assess
amplex
red
cholesterol
assay
kit
accord
protocol
provid
manufactur
use
fluoroskan
ascent
fl
fluoromet
thermo
labsystem
franklin
mean
standard
deviat
independ
measur
present
quantit
analysi
prv
entri
cell
suspens
sk
cell
suspend
ml
rpmi
medium
ml
rpmi
medium
mm
mbcd
incub
h
suspens
tissu
cultur
flask
sarstedt
germani
tilt
platform
wash
pb
prv
ad
cell
moi
cell
incub
h
allow
viru
attach
allow
viru
entri
cell
wash
icecold
pb
fix
pfa
pb
permeabil
triton
pb
stain
phalloidintexa
red
mount
microscop
slide
glycerindabco
cell
analyz
confoc
microscopi
seri
confoc
section
taken
area
within
cell
sequenti
gfp
texa
red
spectrum
merg
imag
virion
section
cell
count
classifi
plasma
membraneassoci
gfp
virion
signal
contact
cortic
actin
signal
perinuclear
zone
experi
perform
time
statist
analysi
perform
spss
softwar
mean
confid
interv
total
number
cellassoci
virion
count
per
cell
percentag
plasma
membraneassoci
virion
present
flow
cytometr
attach
assay
sk
cell
suspend
either
ml
rpmi
medium
ml
rpmi
medium
mm
mbcd
incub
suspens
tilt
platform
cell
wash
pb
incub
rpmi
min
thereaft
cell
inocul
h
icecold
prv
moi
icecold
rpmi
tilt
platform
allow
viru
attach
cell
wash
icecold
pb
flow
cytometr
analysi
perform
facscanto
becton
dickinson
experi
perform
time
test
specif
attach
cell
pretreat
heparin
rpmi
min
cell
incub
min
attach
allow
describ
presenc
heparin
sk
cell
suspens
either
treat
mbcd
inocul
describ
cell
suspens
thereaft
cell
wash
pb
treat
min
trypsin
stock
solut
edta
stock
solut
pb
remov
viru
cell
surfac
wash
pb
cell
fix
pfa
stain
phalloidintexa
red
analyz
confoc
microscopi
describ
cell
suspens
experi
perform
twice
number
plasma
membraneassoci
virion
perinuclear
virion
count
mbcdtreat
cell
either
cell
cell
trypsin
treat
entri
viru
experi
without
pretreat
cell
sk
cell
suspens
inocul
tilt
platform
prv
moi
min
pi
cell
fix
paraformaldehyd
cell
stain
consecut
biotinyl
cholera
toxin
b
subunit
streptavidintexa
red
mount
singl
confoc
scan
perform
top
region
cell
assess
coloc
prv
virion
experi
patch
inocul
cell
perform
describ
harder
et
al
modif
briefli
sk
cell
suspend
rpmi
ml
biotinlabel
cholera
toxin
b
subunit
incub
min
wash
pb
cell
incub
min
streptavidintexa
red
inocul
prv
moi
min
fix
paraformaldehyd
mount
singl
confoc
scan
perform
top
region
cell
assess
coloc
prv
virion
least
cell
analyz
per
sampl
virion
scan
classifi
exactli
coloc
coloc
contact
region
juxtapos
juxta
associ
assoc
control
imag
viru
particl
randomli
posit
cell
construct
merg
unrel
imag
prv
virion
patch
real
control
imag
mix
score
blind
two
research
experi
perform
time
statist
analysi
coloc
data
perform
use
spss
softwar
mean
percentag
viru
particl
per
cell
scan
coloc
juxta
assoc
compar
viru
imag
control
imag
anova
mean
confid
interv
present
